Skip to content
Disclosery

Eversept Partners, LP

Follow

13F filer, CIK 1697013, NEW YORK, NY

Eversept Partners, LP reported $1,087,220,864 across 68 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 53.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697013-25-000008

Period
2025-06-30
Reported value
$1.09B
Holdings
68
Top 10 weight
53.33%
New
19
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PCVXadded+741,444$24.1M
RVTYadded+211,243$20.4M
UNHnew+60,736$18.9M
ILMNnew+198,584$18.9M
AVTRadded+1,403,341$18.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HQYreduced-196,108-$20.5M
HCAreduced-52,519-$20.1M
NBIXexited-167,243-$18.5M
NTRAreduced-97,346-$16.4M
PTGXreduced-269,800-$14.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001697013-25-000008, largest first. % of portfolio is the value over $992,228,456, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 870,193 shares; 2024Q4: 876,766 shares; 2025Q1: 893,721 shares; 2025Q2: 796,375 shares 796,375$135M13.56%-97,346Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,057,206 shares; 2024Q4: 3,661,768 shares; 2025Q1: 2,623,246 shares; 2025Q2: 2,242,388 shares 2,242,388$86.1M8.68%-380,858Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,050,157 shares; 2024Q4: 1,600,015 shares; 2025Q1: 1,898,804 shares; 2025Q2: 2,383,055 shares 2,383,055$56.1M5.66%+484,251Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 469,692 shares; 2024Q4: 392,518 shares; 2025Q1: 299,087 shares; 2025Q2: 510,330 shares 510,330$49.4M4.97%+211,243Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 127,588 shares; 2025Q1: 557,070 shares; 2025Q2: 1,298,514 shares 1,298,514$42.2M4.25%+741,444Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,084 shares; 2024Q4: 175,808 shares; 2025Q1: 152,502 shares; 2025Q2: 99,983 shares 99,983$38.3M3.86%-52,519Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,105,313 shares; 2024Q4: 343,400 shares; 2025Q1: 4,212,270 shares; 2025Q2: 4,065,355 shares 4,065,355$38.1M3.84%-146,915Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 234,934 shares; 2025Q1: 499,207 shares; 2025Q2: 839,284 shares 839,284$34.6M3.48%+340,077Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 691,232 shares; 2024Q4: 779,998 shares; 2025Q1: 1,377,674 shares; 2025Q2: 1,902,539 shares 1,902,539$26.6M2.68%+524,865Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 471,355 shares; 2024Q4: 214,952 shares; 2025Q1: 517,021 shares; 2025Q2: 588,900 shares 588,900$23.3M2.34%+71,879Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 134,959 shares; 2024Q4: 188,493 shares; 2025Q1: 340,339 shares; 2025Q2: 398,726 shares 398,726$21.6M2.18%+58,387Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 276,270 shares; 2024Q4: 294,302 shares; 2025Q1: 186,425 shares; 2025Q2: 164,473 shares 164,473$21.3M2.15%-21,952Timeline
CYHCOMMUNITY HEALTH SYS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,776,455 shares; 2024Q4: 2,827,000 shares; 2025Q1: 8,458,020 shares; 2025Q2: 6,144,384 shares 6,144,384$20.9M2.11%-2,313,636Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 168,369 shares; 2024Q4: 168,369 shares; 2025Q1: 122,823 shares; 2025Q2: 1,526,164 shares 1,526,164$20.5M2.07%+1,403,341Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 663,573 shares; 2024Q4: 299,310 shares; 2025Q1: 280,117 shares; 2025Q2: 394,139 shares 394,139$20.3M2.04%+114,022Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 869,913 shares; 2024Q4: 490,296 shares; 2025Q1: 816,254 shares; 2025Q2: 1,315,033 shares 1,315,033$19.5M1.96%+498,779Timeline
ZIMVIE INCZIMVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,070,780 shares; 2024Q4: 2,070,780 shares; 2025Q1: 2,079,380 shares; 2025Q2: 2,079,380 shares 2,079,380$19.4M1.96%0
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,736 shares 60,736$18.9M1.91%newTimeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 198,584 shares 198,584$18.9M1.91%newTimeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,234,638 shares; 2024Q4: 2,242,125 shares; 2025Q1: 1,410,765 shares; 2025Q2: 1,052,881 shares 1,052,881$17.6M1.78%-357,884Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 564,902 shares; 2024Q4: 719,836 shares; 2025Q1: 696,499 shares; 2025Q2: 838,736 shares 838,736$17.1M1.72%+142,237Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 130,949 shares; 2024Q4: 43,703 shares; 2025Q1: 57,489 shares; 2025Q2: 59,366 shares 59,366$17.1M1.72%+1,877Timeline
HQYHEALTHEQUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 319,078 shares; 2024Q4: 386,697 shares; 2025Q1: 351,976 shares; 2025Q2: 155,868 shares 155,868$16.3M1.65%-196,108Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,138 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 97,604 shares 97,604$15.4M1.55%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,204 shares; 2024Q4: 678,787 shares; 2025Q1: 547,116 shares; 2025Q2: 277,316 shares 277,316$15.3M1.54%-269,800Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,197,189 shares 1,197,189$11.9M1.2%newTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 232,175 shares 232,175$11.8M1.19%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 535,405 shares; 2024Q4: 1,980,312 shares; 2025Q1: 2,172,436 shares; 2025Q2: 1,207,638 shares 1,207,638$10.8M1.09%-964,798Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 453,061 shares; 2024Q4: 383,045 shares; 2025Q1: not reported; 2025Q2: 1,170,311 shares 1,170,311$10.8M1.09%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 33,860 shares; 2024Q4: 22,682 shares; 2025Q1: 27,970 shares; 2025Q2: 43,620 shares 43,620$10.7M1.07%+15,650Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,320,174 shares 7,320,174$10.3M1.04%newTimeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 192,893 shares; 2025Q2: 169,643 shares 169,643$10M1.01%-23,250Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,668 shares; 2024Q4: 19,252 shares; 2025Q1: 10,840 shares; 2025Q2: 64,587 shares 64,587$9.39M0.95%+53,747Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 307,357 shares; 2024Q4: 275,362 shares; 2025Q1: 280,951 shares; 2025Q2: 414,430 shares 414,430$7.51M0.76%+133,479Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 19,465 shares; 2024Q4: 29,178 shares; 2025Q1: 15,698 shares; 2025Q2: 18,962 shares 18,962$7.38M0.74%+3,264Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 13,254 shares 13,254$6.96M0.7%newTimeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 68,258 shares; 2024Q4: 68,258 shares; 2025Q1: 70,329 shares; 2025Q2: 130,924 shares 130,924$6.89M0.69%+60,595
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,588 shares; 2024Q4: not reported; 2025Q1: 23,735 shares; 2025Q2: 20,600 shares 20,600$6.14M0.62%-3,135Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 13,685 shares 13,685$5.55M0.56%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 392,739 shares 392,739$5.15M0.52%newTimeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 38,429 shares; 2024Q4: 22,209 shares; 2025Q1: not reported; 2025Q2: 23,449 shares 23,449$4.63M0.47%newTimeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 137,949 shares; 2024Q4: 571,305 shares; 2025Q1: 150,480 shares; 2025Q2: 358,828 shares 358,828$4.47M0.45%+208,348Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 158,957 shares; 2025Q2: 31,496 shares 31,496$3.25M0.33%-127,461Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 190,531 shares; 2024Q4: 172,103 shares; 2025Q1: 445,588 shares; 2025Q2: 325,479 shares 325,479$3.15M0.32%-120,109Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 115,000 shares 115,000$2.97M0.3%newTimeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 332,756 shares; 2024Q4: 200,095 shares; 2025Q1: 617,418 shares; 2025Q2: 1,986,072 shares 1,986,072$2.78M0.28%+1,368,654Timeline
AMRNAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 167,276 shares 167,276$2.71M0.27%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,992,504 shares; 2024Q4: 911,025 shares; 2025Q1: 697,710 shares; 2025Q2: 697,710 shares 697,710$2.61M0.26%0Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 303,731 shares; 2025Q2: 235,990 shares 235,990$2.32M0.23%-67,741
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,593 shares; 2024Q4: 54,066 shares; 2025Q1: 18,452 shares; 2025Q2: 18,620 shares 18,620$2.32M0.23%+168Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,978,458 shares; 2024Q4: 4,978,458 shares; 2025Q1: 3,896,841 shares; 2025Q2: 1,695,762 shares 1,695,762$2.09M0.21%-2,201,079Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 99,338 shares 99,338$2.06M0.21%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 533,409 shares 533,409$1.85M0.19%newTimeline
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,841,989 shares; 2024Q4: 694,408 shares; 2025Q1: 2,292,261 shares; 2025Q2: 2,292,261 shares 2,292,261$1.64M0.16%0
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 336,966 shares; 2024Q4: not reported; 2025Q1: 942,454 shares; 2025Q2: 640,673 shares 640,673$1.54M0.16%-301,781Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 211,469 shares 211,469$1.47M0.15%newTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 406,558 shares; 2024Q4: 98,895 shares; 2025Q1: 343,947 shares; 2025Q2: 610,231 shares 610,231$1.39M0.14%+266,284Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,621,787 shares; 2024Q4: 492,452 shares; 2025Q1: 1,675,978 shares; 2025Q2: 1,640,430 shares 1,640,430$1.3M0.13%-35,548Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,980 shares 37,980$1.13M0.11%newTimeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 257,154 shares; 2025Q2: 257,154 shares 257,154$1.11M0.11%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 220,196 shares; 2025Q1: 220,196 shares; 2025Q2: 109,324 shares 109,324$1.09M0.11%-110,872
FTREFORTREA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 457,967 shares; 2024Q4: 401,733 shares; 2025Q1: 293,275 shares; 2025Q2: 219,384 shares 219,384$1.08M0.11%-73,891Timeline
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,293,257 shares; 2024Q4: 996,102 shares; 2025Q1: 275,788 shares; 2025Q2: 240,688 shares 240,688$826K0.08%-35,100Timeline
ARCTARCTURUS THERAPEUTICS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 48,364 shares 48,364$629K0.06%newTimeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 89,220 shares; 2025Q2: 128,322 shares 128,322$558K0.06%+39,102Timeline
ModivCare IncModivCare IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares 100,000$312K0.03%new
ACIUAC IMMUNE SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 99,313 shares; 2024Q4: not reported; 2025Q1: 100,752 shares; 2025Q2: 100,752 shares 100,752$205K0.02%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput172,200$95M+48,600

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPYSTATE STR SPDR S&P 500 ETF T76,900$43Mput
NBIXNEUROCRINE BIOSCIENCES INC167,243$18.5Mshares
QQQINVESCO QQQ TR24,003$11.3Mshares
ALGNALIGN TECHNOLOGY INC49,277$7.83Mshares
TFXTELEFLEX INCORPORATED56,630$7.83Mshares
NVAXNOVAVAX INC365,523$2.34Mshares
AMARIN CORP PLCAMARIN CORP PLC3,399,204$1.52Mshares
XOMAXOMA ROYALTY CORPORATION45,017$897Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697013-25-000008 base2025-08-14acceptance time not in the bulk data set